I N D E X , C U R R E N T S C I E N C E R E V I E W S
(Revised August 1997)
NOTICE: This Index to past Current Science Reviews is revised
with each new monthly posting of the CSR. As the revisions are
cumulative, you may safely discard any earlier Index. The CSRs
are posted for the benefit of those listmembers interested in the
status of PD research. For a slightly more detailed explanation of
what this is all about, please see the Introduction dated June 97.
SUBJECT CSR SOURCE JOURNAL JOURNAL REF.
DATE
Absorption, levodopa Jun 96 Neur 1996;46:1051-1054
Acetazolamide (Diamox) Nov 95 Movement Disorders 1993;8:240-241
" Jun 96 Neur 1995;458-460
Acetyl-L Carnitine Oct 96 Neur 1996;47:705-711
ADHD, and dopamine Sep 96 Lancet 27 Jul 1996:255
Agonists, action May 95 Neur 1995;45S3:S5
Albuterol Dec 94 Neur 1994;8:1511-1513
Alternative medicine Oct 96 BMJ 17 Aug 1996
Alzheimer's and PD Apr 95 Ann Neur 1995;37:300-312
" " " Nov 96 J Neur N'surg Psych 1996;61:391-387
Amantadine (Symmetrel) Jul 96 Neur 1996;46:1551-1556
Anticipation Feb 97 Neur 1996;47:1512-1517
Antioxidants, dietary May 97 Mov Disord 1997;12:190-195
Appetite increase Aug 97 Neur 1997;49:310-311
Apolipoprotein E Nov 96 J Neur N'surg Psych 1996;61:347-351
Apomorphine, PD effcts Dec 94 J Neur N'surg Psych 1994;8:998-1001
" , " Aug 96 J Neur N'surg Psych 1996;61:634-637
" , " May 97 Clin Neuropharm 1997;20:165-167
" , availability Apr 95 Lancet 1995;345:517-518
", self-injection Jul 95 J Neur N'surg Psych 1995;58:681-687
", and libido May 97 Clin Neuropharm 1997;20:140-147
Apoptosis Feb 96 Ann Neur 1995;38:839-851
" Dec 96 Science News 16 Nov 96:316
" Mar 97 Science 21 Feb 97;1081-82
" Apr 97 J Neurosci 1997;17:1075-1085
" Apr 97 J Neurosci 1007;17:1397-1405
" ,l-dopa induced Feb 97 Mov Disord 1997;12:17-23
Artane, withdrawal Mar 97 Ann Neur 1997;41:133
Autonomous deficit Apr 97 Neur 1997;48:662-667
Axial motor control Feb 97 J Neur N'surg Psych 1996;61:645-648
Behavioral treatment Aug 97 Mov Disord 1997;12:306-314
Blink reflex, and PD Dec 96 J Neurosci 1996;16:7308-7330
Botulinum toxin Jun 96 Neur 1995;45:822-824
" Aug 96 Arch Neur 1996;53:617-624
" Aug 96 J Neur N'surg Psych 1996;61:693
Boxers, parkinsonism Jul 95 J Neur N'surg Psych 1995;58:688-691
Brain injury Jan 97 Neur 1996;47:1358-1359
Bradykinesia Sep 96 Brain 1996;119:801-813
Bromocryptine Dec 94 J Neur N'surg Psych 1994;8:903-910
" Mar 96 Lancet 20 Jan 1996:196
" plus levodopa May 97 Clin Neuropharm 1997;20;67-76
Bruxism Feb 97 Mov Disord 1997;12:73-78
Cabergoline Jan 95 Arch Neur 1994;51:1236-1241
" Dec 95 Lancet 11 Nov 1995:1290
" Jun 96 Neur 1996;46:1062-1065
" Mar 97 Neur 1997;48:363-368
Carnitine, Acetyl-L Oct 96 Neur 1996:47:705-711
Cerebellum, in ET Jun 96 Neur 1996;46:1200-1205
" " Jun 96 Ann Neur 1996;39:650-658
" ,cognition in May 97 Science 28 Mar 97:1940-43
Chocolate and red wine Oct 96 Lancet 21 Sep 96:834
Cinnarizine Feb 97 Mov Disord 1997;12:107-110
Cisapride Aug 97 Mov Disord 1997;12:423-425
Clonidine Aug 97 Lancet 28 Jun 97:1877-81
Clozapine (Clozaril) Apr 95 Lancet 1995;345:517-518
" Apr 95 Neur 1995;45:432-434
" Jan 97 BMJ 16 Nov 1996:1313
" for dyskinesia Apr 97 Neur 1997;48:658-662
" relieves "off" May 97 Mov Disord 1997;12:159-166
" for tremor May 97 Neur 1997;48:1077-1091
Cocaine, effect Jan 97 J Neurosci 1996;16:7670-7677
Cognitive decline Feb 95 J Neur N'surg Psych 1995;58:51-55
" Jun 96 J Neur N'surg Psych 1996;60:564-571
" Jan 97 J Neurosci 1996;16:7768-7775
" Mar 97 Brain 1996;119:2121-32
" Mar 97 Neur 1997;48:546-547
" Apr 97 Arch Neur 1997;54:296-302
Color discrimination Mar 95 Neur 1995;45:386-387
" Jul 95 Brain 1995;118:771-778
Complex I (enzyme) Nov 96 Ann Neur 1996;40:663-671
" Feb 97 Mov Disord 1997;12:3-8
Constipation Nov 95 Lancet 1995;346:861-864
" Aug 97 Mov Disord 1997:12:423-425
DATATOP Nov 95 Arch Neur 1995;52:565-570
" Mar 96 Ann Neur 1996;39:29-36
" Mar 97 Ann Neur 1996;40:946-949
" , end point in May 97 Mov Disord 1997;12:183-189
Deep-brain stimulation Oct 96 Arch Neur
1996;53:898-903 " Jun 96 Neur
1996;46:1150-1153
" Aug 97 Neur 1997;49:259-253
" vs pallidotomy Jul 97 Nat Med 1997;3:671-674
" " Jul 97 Nat Med 1997;3:602-603
" for ET Aug 97 Mov Disord 1997;12:337-341
Dementia, PD vs AD Jul 95 Neur 1995;45:1025
" , Downs and Apr 97 J Neur N'Surg Psych 1997;62:289
" ,frontotemporal Jul 97 Ann Neur 1997;41:706-715
" , preclinical Jan 96 Neur 1995;45:1691-1696
" , incidence Jun 96 Neur 1995;45:705-708
" , " Jul 96 Arch Neur 1996;53:538-542
" , tacrine for Oct 96 J Neur N'surg Psych 1996;61:324-325
" , wine prevents May 97 BMJ 5 Apr 97:997
Depression Mar 96 Arch Neur 1996;53:175-179
" Jan 97 Neur 1996;47:1148-1152
" Jun 97 Arch Neur 1997;54:625-630
Diagnosis, clinical Apr 97 Brain 1997;120:75-90
" , " Apr 97 J Neur N'Surg Psych 1997;62:245-252
Dimethyl Selegiline Aug 97 J Neurochem 1997;68:434-436
DLBD Jun 96 J Neur N'surg Psych 1996;60:531-538
" ,FD-PET diagnosis Sep 96 Neur 1996;47:462-466
Dopamine, non-PD use Apr 97 BMJ 8 Mar 97:689-690
" receptors Nov 96 J Neurosci 1996;16:6579-6591
" " Feb 97 Mov Disord 1997;12:33-38
" " Jul 97 Neur 1997;48:1589-1593
" storage sites Nov 96 J Neurosci 1996;16:4135-4145
" transporter Mar 96 Science 16 Feb 1996:909
" " Apr 97 J Neurosci 1997;17:960-974
" " Jul 97 Neur 1997;48:1578-1583
Down's syndrome Feb 95 Neur 1994;44:2419
Driving ability Feb 96 JAMA 17 Jan 1996:182
" Aug 96 J Neur N'surg Psych 1996;61:621-627
Drug Industry hype Nov 96 Time 21 Oct 1996:92
Drug strategy Aug 97 Neur 1997;49S1:S2-S62
Dyskinesia Jul 96 Neur 1996;46:1548-1551
" Mar 97 Neur 1997;48:369-372
" , clozapine for Apr 97 Neur 1997;48:658-682
" , DA-induced May 97 Mov Disord 1997;12:148-158
Eldepryl (selegiline) Dec 94 Ann Neur 1994;36;759-764
Electroconvulsive (PSP)Jun 96 Neur 1996;46:1284-1286
" (PD) Aug 96 J Neur N'surg Psych 1996;61:693-694
Encephalitis, childhoodJun 96 J Neur N'surg Psych 1996;60:589
Entacapone Feb 96 J Neur N'surg Psych 1996;60:36-40
Enteric nervous system Jun 96 NEJM 25 Apr 96:1106-15
Essential tremor, VIM Jun 96 Neur 1996;46:1150-1153
" , and PD Jun 96 Neur 1995;45:645-648
" , botulinum Jun 96 Neur 1995;45:822-824
" , and DBS Aug 97 Mov Disord 1997;12:337-341
" , migraine Jun 96 Neur 1996;46:458-460
" , etiology Jun 96 Neur 1996;46:1200-1205
" " Sep 96 Neur 1996;47:264-265
" " Mar 97 Ann Neur 1997;411:32-40
" " Aug 97 J Neurol Sci 1997;149:195-196
" , PET scan Jun 96 Ann Neur 1996;39:650-658
" " Jan 97 Neur 1996;47:1331-1332
Ethanol and ET Jun 96 Ann Neur 1996;39:650-658
" Mar 97 Ann Neur 1996;40:950
Etiology of PD Jun 96 Neur 1996;46:1044-1050
" Jun 96 Neur 1996;46:1270-1274
" Jun 96 Neur 1996;46:1275-1284
" Aug 96 J Neur N'surg Psych 1996;61:4-16
" Sep 96 Arch Neur 1996;53;721
" Oct 96 Neur 1996;47:636-643
" Oct 96 Neur 1996;47:644-650
" Mar 97 Arch Neur 1997;54:145-150
" Apr 97 Neur 1997;48:650-658
Expression Jan 96 Neur 1995;45:1696-1702
Eye movement Jan 95 Neur 1994;44:2285
Fetal transplant Oct 95 Ann Neur 1995;38:379-388
" Apr 96 Brain 1996;119:41-50
" Dec 96 Lancet 26 Oct 1996;1159
" , fatal Jul 97 Neur 1997;48:1737-1738
" , FDA and Apr 97 Lancet 16 Mar 1997;784
" ,(pig) Nov 95 Science News 7 Oct 1995:230
" , " Mar 97 Science 24 Jan 1997:473
" , " Apr 97 BMJ 1 Mar 1997;625
" , " Jul 97 Nat Med 1997;3:474-475
" , " Aug 97 Nat Med 1997;3:350-353
" research Dec 96 J Neurosci 1996;16:6966-6974
" " Dec 96 J Neurosci 1996;16:7216-7227
" , effects Jul 97 J Neurosurg 1997;86:931-942
" , survival Aug 97 Exp Neur 1997;144:41-46
" , " Aug 97 Ann Neur 1997;42:95-107
Fluctuations, motor Aug 97 Mov Disord 1997:12:285-292
Fluctuations, nonmotor Jan 97 Neur 1996;47:1180-1183
Flunarizine Feb 97 Movem't Dis 1997;12:107-110
Food And Drug Adm. Jul 97 Nat Med 1997;3:477
Food habits and PD Oct 96 Neur 1996;47:636-643
Free radicals Jun 96 Science News 18 May 1996:311
Freezing, in non-IPD Aug 97 Mov Disord 1997;12:302-305
Freezing, help for May 97 Mov Disord 1997;12:206-215
Gabapentin for RLS May 97 Clin Neuropharm 1997;20:148-151
Gait, improvement Jul 96 Brain 1996;119:551-558
" impairment Jan 97 Brain 1996;119:1705-16
Gamma knife Jun 96 Ann Neur 1996;39:535-538
Ganglioside GM1 Sep 95 Neur 1995;45:1149-1154
GDNF Dec 96 J Neurosci 1996;16:7206-7215
" Jan 97 J Neurosci 1996;16:8132-8139
" Mar 97 Science 7 Feb 97:838-841
Gene CYP2D6, and risk Sep 96 Neur 1996;47:225-230
Gene, mutation Jun 95 Lancet 1995;345:958
" Jan 96 Neur 1995;45:1760-1763
" Dec 96 Science 15 Nov 96;1197-99
" Jan 97 BMJ 23 Nov 96;1278
" Jan 97 Ann Neur 1996;40:767-775
" Mar 97 Ann Neur 1997;41:277-281
" Jul 97 Ann Neur 1997;41:814
" Aug 97 Science 27 Jun 97:2045
" Aug 97 Science News 28 Jun 97:396
Gene transfer Aug 95 Science News 29 Jul 1995:73
" May 96 Science 12 Apr 1996;263
" Aug 97 Nat Med 1997;3:357-359
" Aug 97 Brain 1997;120:1245-59
Glucose tolerance Jan 96 Int J Neur 1994;69:125-130
Glutamate antagonist Jun 96 Ann Neur 1996;39:574-578
" Jun 96 Ann Neur 1996;39:557-558
" Nov 96 J Neurosci 1996;16:4231-4239
" Nov 96 J Neurosci 1996;16:6394-6401
" , toxicity Jan 97 Science 6 Dec 1996:1612
Glutamic acid RNA Sep 96 Neur 1996;47:219-224
Guillain-Barre Sep 95 Ann Neur 1995;38:218-224
Hallucinations Jun 96 Neur 1995;45:659-671
" Jan 97 Arch Neur 1996;53:1265-1268
Heredity Apr 95 Neur 1995;45:502-506
" Oct 95 Ann Neur 1995;38:373-378
" Feb 96 Science News 6 Jan 96:4
" Jun 96 Neur 1996;46:1275-1284
" Sep 96 Neur 1996;47:155-160
" Sep 96 Neur 1996;47:160-166
" Mar 97 Ann Neur 1997;41:265-268
" Mar 97 Ann Neur 1997;41:222-229
Histaminergic neurons Jul 96 Neur 1996;46:1693-1696
Hitler's PD observed May 97 Movem't Dis 1997;12:239-240
Hydrocarbon, caused by Mar 97 Ann Neur 1996;40:922-925
Incidence (survey) Jun 97 Neur 1997;48:1277-1281
" , Argentina May 97 Movem't Dis 1998;12:197-205
Inderal, for dyskinesiaJul 96 Neur 1996;46:1548-1551
Iron, possible cause Jul 96 Lancet 8 Jun 1996;1614
Iron, elevated Jan 95 Ann Neur 1994;36;876-881
" Oct 95 Neur 1995;45:1138-1143
Juvenile PD Sep 96 Neur 1996;47:160-166
Kava Jun 95 J Neur N'surg Psych 1995;58:639-640
Keats, John Jan 95 Arch Neur 1994;51:1182-1183
Lamotrigine Jun 97 Neur 1997;48:1282-1286
Lazabemide Aug 96 Ann Neur 1996;40:99-107
Leukemia drugs Jul 95 Ann Neur 1995;37:810-814
Levodopa strategy Oct 95 Ann Neur 1995;38:389-395
" Dec 95 J Neur N'surg Psych 1995;59:555
" Feb 97 Neur 1996;47:Supp 3
Levodopa effects Jan 96 Neur 1995;45:1757-1760
" Jun 96 Neur 1996;46:1430-1436
" Aug 96 J Neur N'surg Psych 1996;61:634-637
" Feb 97 Mov Disord 1997;12:103-106
